LEADER 01520nam 2200409 a 450 001 9910693068103321 005 20040922091104.0 035 $a(CKB)5470000002358822 035 $a(OCoLC)56554612 035 9 $aocm56554612 035 $a(OCoLC)995470000002358822 035 $a(EXLCZ)995470000002358822 100 $a20040922d2004 ua 0 101 0 $aeng 135 $aurmn|||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aMedicare$b[electronic resource] $ecall centers need to improve responses to policy-oriented questions from providers : report to the Ranking Minority Member, Subcommittee on Health, Committee on Ways and Means, House of Representatives 210 1$a[Washington, D.C.] :$cU.S. Government Accountability Office,$d[2004] 300 $aTitle from title screen (viewed on Sept. 16, 2004). 300 $a"July 2004." 300 $aPaper version available from: U.S. Government Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548. 300 $a"GAO-04-669." 320 $aIncludes bibliographical references. 517 $aMedicare 606 $aMedicare 606 $aCall centers$xEvaluation 615 0$aMedicare. 615 0$aCall centers$xEvaluation. 712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Ways and Means.$bSubcommittee on Health. 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910693068103321 996 $aMedicare$92879855 997 $aUNINA LEADER 02945nam 2200649 a 450 001 9910799978603321 005 20230801183925.0 010 $a1-134-42885-5 010 $a0-203-46083-9 010 $a1-280-07257-1 010 $a0-203-45117-1 035 $a(CKB)1000000000254408 035 $a(EBL)181899 035 $a(OCoLC)475893571 035 $a(SSID)ssj0000290547 035 $a(PQKBManifestationID)11215339 035 $a(PQKBTitleCode)TC0000290547 035 $a(PQKBWorkID)10410053 035 $a(PQKB)10477408 035 $a(MiAaPQ)EBC181899 035 $a(Au-PeEL)EBL181899 035 $a(CaPaEBR)ebr10100507 035 $a(CaONFJC)MIL7257 035 $a(EXLCZ)991000000000254408 100 $a20020930d2003 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 14$aThe Buddhist unconscious $ethe a?laya-vijn?a?na in the context of Indian Buddhist thought /$fWilliam S. Waldron 210 $aLondon ;$aNew York $cRoutledgeCurzon$d2003 215 $a1 online resource (xvi, 269 pages) 225 1 $aRoutledgeCurzon critical studies in Buddhism 300 $aDescription based upon print version of record. 311 0 $a0-415-40607-2 311 0 $a0-415-29809-1 320 $aIncludes bibliographical references (p. 247-253) and indexes. 327 $aBook Cover; Title; Contents; Preface; Acknowledgments; Thematic introduction: a Buddhist critique of the construction of self and world; The background and context of the alaya-vijana; The early Buddhist background; The Abhidharma context; The alaya-vijana in the Yogacara tradition; The alaya-vijana in the early tradition; The alaya-vijana in the Mahayana-sagraha 1. bringing it all back home; The alaya-vijana in the Mahayana-sagraha 2. looking beyond; Appendices; The series of dependent arising: affliction, action, and their results; Index of related controversies 327 $aTranslation: the Pravtti and Nivtti Portions of the Vinicayasagraha of the Yogacarabhmi; Notes; Bibliography of works cited; Index of texts quoted; Index 330 $aThis study focuses on the development of the concept of unconscious mind within Indian Buddhist thought, presents issues of conception of mind and examines the doctrinal and philosophical arguments described and defended it. 410 0$aRoutledgeCurzon critical studies in Buddhism. 606 $aA?layavijn?a?na 606 $aYoga?ca?ra (Buddhism) 606 $aMa?dhyamika (Buddhism) 615 0$aA?layavijn?a?na. 615 0$aYoga?ca?ra (Buddhism) 615 0$aMa?dhyamika (Buddhism) 676 $a294.3/42042 700 $aWaldron$b William S.$f1954-$01586662 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910799978603321 996 $aThe Buddhist unconscious$93873381 997 $aUNINA LEADER 06192nam 22008055 450 001 9910298354003321 005 20200701160112.0 010 $a1-4614-8993-8 024 7 $a10.1007/978-1-4614-8993-1 035 $a(CKB)2550000001151684 035 $a(EBL)1538662 035 $a(SSID)ssj0001049030 035 $a(PQKBManifestationID)11623067 035 $a(PQKBTitleCode)TC0001049030 035 $a(PQKBWorkID)11033665 035 $a(PQKB)10523004 035 $a(MiAaPQ)EBC1538662 035 $a(DE-He213)978-1-4614-8993-1 035 $a(PPN)176100253 035 $a(EXLCZ)992550000001151684 100 $a20131024d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aNanotoxicology $eMaterials, Methodologies, and Assessments /$fedited by Nelson Durán, Silvia S. Guterres, Oswaldo L. Alves 205 $a1st ed. 2014. 210 1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2014. 215 $a1 online resource (415 p.) 225 1 $aNanomedicine and Nanotoxicology,$x2194-0452 300 $aDescription based upon print version of record. 311 $a1-4614-8992-X 320 $aIncludes bibliographical references and index. 327 $aForeword -- Preface -- Chapter 1: Nanomaterials -- Chapter 2: Concepts and Methodology of Interaction of Carbon Nanostructures with Cellular Systems -- Chapter 3: Nanostability -- Chapter 4: Pharmacokinetics and Phamacodynamics of Nanomaterials -- Chapter 5: In Vitro Cytotoxicity Assays of Nanoparticles on Different Cell Lines -- Chapter 6: Carbon Nanotubes: From Synthesis to Genotoxicity -- Chapter 7: From Combinatorial Display Techniques to Microarray Technology: New Approaches to the Development and Toxicological Profiling of Targeted Nanomedicines -- Chapter 8: Genetic Studies on the Effects of Nanomaterials -- Chapter 9: Cellular Mechanisms in Nanomaterial Internalization, Intracellular Trafficking and Toxicity -- Chapter 10: Cytotoxicity and Genotoxicity of Solid Lipid Nanoparticles -- Chapter 11: Cytotoxicity and Genotoxicity of Biogenically Synthesized Silver Nanoparticles -- Chapter 12: Cytotoxicity and Genotoxicity of Iron Oxides Nanoparticles -- Chapter 13: Poloxamers as Drug-Delivery Systems: Physico-Chemical, Pharmaceutical And Toxicological Aspects -- Chapter 14: Polymeric Nanoparticles: In Vivo Toxicological Evaluation, Cardiotoxicity and Hepatotoxicity -- Chapter 15: Cyto,Geno and Ecotoxicity of Copper Nanoparticles -- Chapter 16: Accessing the Erythrocyte Toxicity of Nanomaterials: From Current Methods to Biomolecular Surface Chemistry Interactions -- Index. 330 $aThis book takes a systematic approach to nanotoxicology and the developing risk factors associated with  nanosized particles during manufacture and use of nanotechnology. Beginning with a detailed introduction to engineered nanostructures, the first part of the book presents concepts and definitions of nanomaterials from quantum dots to graphene to fullerenes, with detailed discussion of functionalization, stability, and medical and biological applications. The second part critically examines methodologies used to assess cytotoxicity and genotoxicity. Coverage includes interactions with blood (erythrocytes), combinatorial and microarray techniques, cellular mechanisms, and ecotoxicology assessments. Part three describes cases studies both in vitro and in vivo for specific nanomaterials including solid lipid nanoparticles and nanostructured lipid carriers and metallic nanoparticles and metallic oxides. New information is also presented on toxicological aspects of poloxamers and polymeric nanoparticles as drug carriers as well as size effects on cytotoxicity and genotoxicity. Didactic aspects are emphasized in all chapters, making the book suitable for a broad audience ranging from advanced undergraduate and graduate students to researchers in academia and industry. In all, Nanotoxicology: Materials, Methodologies, and Assessments will provide comprehensive insight into biological and environmental interactions with nanostructures. Provides an introduction to nanostructures actually in use Describes cyto- and genotoxicity methodologies, and assesses their performance in comparison to common toxicity assays Discusses the relation of cytotoxicity and genotoxicity to ecotoxicity Presents a range of applications, from biogenic silver nanoparticles to poloxamers as drug-delivery systems, reflecting the expanding applications of nanotechnology. 410 0$aNanomedicine and Nanotoxicology,$x2194-0452 606 $aPharmacology 606 $aNanochemistry 606 $aEnvironmental toxicology 606 $aNanotechnology 606 $aNanoscience 606 $aNanoscience 606 $aNanostructures 606 $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007 606 $aNanochemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/C33000 606 $aEcotoxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/U25001 606 $aNanotechnology$3https://scigraph.springernature.com/ontologies/product-market-codes/Z14000 606 $aNanoscale Science and Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/P25140 615 0$aPharmacology. 615 0$aNanochemistry. 615 0$aEnvironmental toxicology. 615 0$aNanotechnology. 615 0$aNanoscience. 615 0$aNanoscience. 615 0$aNanostructures. 615 14$aPharmacology/Toxicology. 615 24$aNanochemistry. 615 24$aEcotoxicology. 615 24$aNanotechnology. 615 24$aNanoscale Science and Technology. 676 $a541.2 676 $a615.1/901 702 $aDurán$b Nelson$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aGuterres$b Silvia S$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aAlves$b Oswaldo L$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910298354003321 996 $aNanotoxicology$92052322 997 $aUNINA